ARWR
Arrowhead Pharmaceuticals Inc
64.20$
-0.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 79,337.6% | 414.2% | 155.0% | 148.7% | 204.4% | 461.1% | 2,234.8% | 2,127.0% | 188.3% | 0.0% | – | – | – | – | – | – | – | – | – | – | – | 9.4% | 1.7% | 8.0% | 8.4% | 4.3% | 1.8% | 20.7% | 24.0% | 120.1% | – | – | 21.3% | 209.4% | 1.1% | 22.4% | 2.5% | 2.4% | 8.6% | – | – | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 90.6% | 98.3% | 92.0% | 91.6% | 95.7% | 98.2% | 79.3% | 76.0% | -20.1% | – | – | -21.3% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 37,349.1% | 218.2% | 77.6% | 73.9% | 95.0% | 240.2% | 1,670.0% | 1,496.1% | 131.2% | 47.3% | 40.8% | 42.8% | 51.5% | 75.6% | 120.0% | 113.9% | 548.5% | 171.6% | 136.2% | 129.3% | 171.8% | 231.8% | 48.6% | 215.9% | 256.9% | 130.2% | 49.6% | 580.6% | 598.9% | 3,172.1% | – | – | 557.0% | 5,480.1% | 24.5% | 584.8% | 68.1% | 67.1% | 235.0% | 263.4% | 108.0% | |
| 41,993.1% | 196.0% | 40.9% | 42.0% | 109.4% | 125.2% | 565.1% | 631.6% | 57.1% | 17.7% | 11.1% | 11.3% | 23.7% | 36.6% | 68.7% | 38.7% | 186.9% | 40.6% | 49.3% | 38.9% | 100.0% | 89.6% | 22.3% | 101.0% | 100.2% | 32.9% | 15.6% | 147.7% | 150.1% | 653.1% | – | – | 109.3% | 1,056.0% | 5.1% | 109.6% | 14.5% | 17.2% | 55.9% | 62.0% | 25.5% | |
| 79,342.2% | 414.2% | 155.0% | 148.7% | 204.4% | 461.0% | 2,235.1% | 2,126.9% | 188.3% | 65.0% | 51.8% | 54.1% | 75.2% | 112.2% | 188.7% | 152.6% | 733.4% | 212.9% | 186.0% | 169.4% | 269.5% | 321.4% | 70.9% | 316.9% | 357.1% | 163.1% | 65.2% | 728.3% | 749.0% | 3,825.2% | – | – | 666.3% | 6,556.5% | 29.8% | 696.2% | 82.8% | 84.5% | 291.6% | 326.0% | 133.8% | |
| -69,744.4% | -341.4% | -68.2% | -61.2% | -117.6% | -393.6% | -2,312.5% | -2,188.7% | -99.2% | 31.6% | 45.7% | 43.6% | 22.3% | -16.5% | -94.5% | -58.2% | -656.6% | -112.9% | -86.0% | -69.4% | -169.5% | -230.8% | 27.4% | -224.9% | -265.5% | -67.4% | 32.9% | -649.0% | -673.0% | -3,845.3% | – | – | -687.6% | -6,456.5% | 70.2% | -596.2% | 17.2% | 15.5% | -191.6% | -226.0% | -33.8% | |
| 850,540.8% | 576.1% | 1.2% | 1,406.0% | 4,764.0% | 4,664.9% | 25.9% | 43,128.0% | 9,316.1% | 3,148.2% | 3.9% | 4,075.2% | 16,071.4% | 7,400.7% | 10.2% | 8,528.1% | 120,407.1% | 10.2% | 4.6% | 2.8% | 16.0% | 4.2% | 0.7% | 3.8% | 5.0% | 4.6% | 3.5% | 32.6% | 32.7% | 151.1% | – | – | 62.1% | 865.8% | 4.0% | 87.8% | 8.5% | 8.5% | 32.3% | 32.6% | 13.8% | |
| -71,102.7% | -276.9% | -67.2% | -59.1% | -123.1% | -376.1% | -2,289.5% | -2,145.5% | -95.6% | 34.7% | 49.6% | 47.6% | 27.4% | -9.1% | -84.3% | -49.7% | -634.5% | -97.3% | -81.7% | -65.2% | -165.5% | -229.1% | 29.2% | -222.3% | -260.2% | -66.8% | 32.6% | -653.3% | -677.1% | -3,905.6% | – | – | -732.5% | -7,004.6% | 68.1% | -645.0% | 14.1% | 10.7% | -186.6% | -237.7% | -37.7% | |
| 7.7% | -34.6% | -0.9% | -2.1% | 0.0% | -17.5% | -23.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.4% | 0.0% | – | – | 0.0% | -10.2% | -4.6% | -2.8% | 0.0% | -4.2% | -1.9% | -2.7% | 12.0% | 0.0% | -0.7% | 4.7% | 12.6% | -93.3% | – | – | 2.3% | 4.1% | 0.3% | -1.6% | 7.8% | 0.0% | 0.0% | 0.0% | 3.0% | |
| -71,110.4% | -276.9% | -67.2% | -59.1% | -123.2% | -376.1% | -2,289.5% | -2,145.5% | -95.6% | 34.7% | 49.6% | 47.6% | 27.0% | -9.1% | -84.3% | -49.7% | -634.5% | -97.3% | -81.7% | -65.2% | -165.5% | -229.1% | 29.2% | -222.3% | -270.8% | -66.1% | 33.3% | -650.5% | -681.4% | -3,741.6% | – | – | -722.9% | -6,923.4% | 68.3% | -631.1% | -9.3% | 11.7% | -180.0% | -258.2% | -47.8% | |
| -60,482.3% | -314.2% | -55.0% | -48.7% | -104.4% | -361.1% | -2,135.1% | -2,026.9% | -88.3% | 35.0% | 48.2% | 45.9% | 24.8% | -12.2% | -88.7% | -52.6% | -633.4% | -104.2% | -80.2% | -65.1% | -162.9% | -221.4% | 30.9% | -214.3% | -257.1% | -58.0% | 37.9% | -600.0% | -620.4% | -3,634.4% | – | – | -649.1% | -5,929.4% | 73.2% | -534.7% | 25.0% | 21.7% | -145.6% | -205.1% | -21.0% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.